RenovoRx : Toxicity and Efficacy of Stereotactic Body Radiation Therapy vs. Intensity-Modulated Radiation Therapy for the Treatment of Locally Advanced Pancreatic Cancer in a Phase 3 Trial Presented at the 2023 ASCO Gastrointestinal (ASCO GI) Cancers Symp

Press/Media

Period21 Jan 2023

Media coverage

1

Media coverage

  • TitleRenovoRx : Toxicity and Efficacy of Stereotactic Body Radiation Therapy vs. Intensity-Modulated Radiation Therapy for the Treatment of Locally Advanced Pancreatic Cancer in a Phase 3 Trial Presented at the 2023 ASCO Gastrointestinal (ASCO GI) Cancers Symp
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date21/01/23
    URLct.moreover.com/?a=49801995277&p=1gw&v=1&x=MbW2w_FuDnHiE6UzFmeYJQ
    PersonsKaryn Goodman
View all 1
View less